Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Huapont Life Science Co's quarterly market cap
increased
from Dec. 2025 (¥9,430 Mil) to Mar. 2026 (¥10,318 Mil) but then
declined
from Mar. 2026 (¥10,318 Mil) to Jun. 2026 (¥7,753 Mil).
Huapont Life Science Co's annual market cap
declined
from Dec. 2023 (¥9,226 Mil) to Dec. 2024 (¥8,917 Mil) but then
increased
from Dec. 2024 (¥8,917 Mil) to Dec. 2025 (¥9,430 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Huapont Life Science Co's Enterprise Value for Today is ¥18,774 Mil.
Huapont Life Science Co (SZSE:002004) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Huapont Life Science Co Market Cap Related Terms
Huapont Life Science Co Market Cap Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SZSE:002004 vs CTVA, CF, MOS: Market Cap Comparison
For the Agricultural Inputs subindustry, Huapont Life Science Co's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Huapont Life Science Co Market Cap vs Agriculture Industry
For the Agriculture industry and Basic Materials sector, Huapont Life Science Co's Market Cap distribution charts can be found below:
* The bar in red indicates where Huapont Life Science Co's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Huapont Life Science Co's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Huapont Life Science Co (SZSE:002004) has a Market Cap of ¥8,672 Mil as of Sep. 20, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Huapont Life Science Co and its competitors. According to the industry distribution chart, Huapont Life Science Co ranks #51 out of 265 companies in the Agriculture industry, placing it in the top 19.2%.
Is Huapont Life Science Co's Market Cap too high?
Huapont Life Science Co's current Market Cap is ¥8,672 Mil. Based on the distribution chart, Huapont Life Science Co ranks #51 out of 265 companies in the Agriculture industry, which is in the top quartile — a strong position relative to peers. Overall, Huapont Life Science Co has a GF Score™ of 65/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Huapont Life Science Co's Market Cap compare to CTVA and CF?
According to the Agriculture industry distribution chart, Huapont Life Science Co ranks #51 out of 265 companies for Market Cap. This places Huapont Life Science Co in the top 19% of its industry — outperforming the majority of peers. The industry median Market Cap is 208.22. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for an Agriculture company?
The median Market Cap among Agriculture companies is 208.22, based on 265 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Huapont Life Science Co and its competitors. For the Agriculture industry, the median Market Cap is 208.22 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Huapont Life Science Co's current Market Cap is ¥8,672 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Huapont Life Science Co stock overvalued right now?
Based on GuruFocus' analysis, Huapont Life Science Co (SZSE:002004) is currently considered Fairly Valued. The stock's GF Value™ is ¥4.43, compared to a current price of ¥4.38 — trading 1.1% below its estimated fair value. The current Market Cap is ¥8,672 Mil. Huapont Life Science Co's overall GF Score™ is 65/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Huapont Life Science Co (SZSE:002004), the current Market Cap is ¥8,672 Mil as of Sep. 20, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Huapont Life Science Co (SZSE:002004) Overvalued in 2026?
Based on GuruFocus' analysis, Huapont Life Science Co stock appears to be undervalued.
The current stock price of ¥4.38 is trading 1.1% below its estimated GF Value™ of ¥4.43.
GuruFocus considers Huapont Life Science Co to be Fairly Valued.
Key valuation signals for SZSE:002004:
Market Cap: ¥8,672 Mil
GF Value™: ¥4.43 vs. price of ¥4.38 (1.1% below fair value)
No single metric tells the full story. See the SZSE:002004 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Huapont Life Science Co Ltd is a China-based company engaged in the manufacturing and distribution of pharmaceutical products. In addition, the company is also engaged in the agrochemical business and medical business. The agrochemical department is mainly engaged in the research and development, production, sales, and technical services of pesticide intermediates, original drugs, and preparations.
65GF Score
Get the complete analysis for SZSE:002004
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SZSE:002004 has been successfully added to your 
